MDAX

EQS-News: Evotec and TIAP expand LAB150 BRIDGE partnership to include Amgen

Retrieved on: 
Saturday, October 22, 2022
LinkedIn, Therapy, Disease, Fortune, Efficiency, Amgen, Federal Economic Development Initiative for Northern Ontario, Science, ESG, Dow Jones Industrial Average, NASDAQ, Patient, Barron's, Investor, Biology, Biotechnology, Research, Twitter, MDAX, Partnership, ISIN, University, Drug discovery, The 1972 Annual World's Best SF, Frankfurt Stock Exchange, Industry, Neurology, General Grievous, CEO, Ecosystem, Genetics, News, Federal Economic Development Agency for Southern Ontario, Toronto, EVO, Communication, Biomedical Research, Solution, Security (finance), Pharmaceutical industry, Fine chemical, Evotec, Greater Toronto Area

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and Toronto Innovation Acceleration Partners (TIAP) today announced that the two companies have expanded LAB150, their translational BRIDGE partnership, to include Amgen as a strategic partner.

Key Points: 
  • Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and Toronto Innovation Acceleration Partners (TIAP) today announced that the two companies have expanded LAB150, their translational BRIDGE partnership, to include Amgen as a strategic partner.
  • LAB150 was created by Evotec and TIAP in 2017 to accelerate Torontos academic research into market-ready products.
  • Amgen will provide financial support for chosen LAB150 projects along with significant mentorship from their drug discovery and development teams.
  • Together with Evotec, we look forward to collaborating with Amgen to bring enhanced expertise and capital to LAB150 to enable life science company creation, said Parimal Nathwani, President and CEO of TIAP.

EQS-News: KION Group appoints new Chief Financial Officer and Chief People and Sustainability Officer

Retrieved on: 
Saturday, October 22, 2022
People, CFO, Communication, Sale, Culture, Frankfurt, Supervisory board, KION Group, Sustainability, Occupational safety and health, RTÉ Executive Board, Rolls-Royce Power Systems, MDAX, Coronavirus, Senvion, Automation, KION, CPSO, Board of directors, Group, Accounting, Industry, Legislation, Heidelberger Druckmaschinen, Organization, Environment, Prospectus, Record, Daimler Trucks North America, Industrial relations, Solution, Risk, Security (finance), Management

Frankfurt/Main, October 20, 2022 KION GROUP AG announces the completion of its Executive Board with the appointments of Marcus Wassenberg as Group Chief Financial Officer (CFO) and Valeria Gargiulo as Chief People and Sustainability Officer (CPSO).

Key Points: 
  • Frankfurt/Main, October 20, 2022 KION GROUP AG announces the completion of its Executive Board with the appointments of Marcus Wassenberg as Group Chief Financial Officer (CFO) and Valeria Gargiulo as Chief People and Sustainability Officer (CPSO).
  • Marcus Wassenberg (55) joins KION GROUP AG as CFO from Heidelberger Druckmaschinen AG.
  • Valeria Gargiulo (50) joins KION Group AG from Daimler Truck AG and will assume her new role as Chief People and Sustainability Officer in Frankfurt/Main by May 1, 2023, at the latest.
  • Rob Smith, Chief Executive Officer of the KION GROUP, added: We at KION are focused on delivering profitable growth for the benefit of our stakeholders.

EQS-News: Encavis Asset Management AG continues success story as accelerator of the energy transition and extends with the member of the Executive Board Alexander Stütz

Retrieved on: 
Saturday, October 22, 2022
MSCI, Supervision, Insurance, United Nations Global Compact, Growth, Supervisory board, ESG, ISS, RTÉ Executive Board, Investment, MDAX, ISIN, Company, Industry, Board of directors, Wind, UN, David Ipp, Primary energy, Solution, CO2, Pension fund, Renewable energy, Ticker

Encavis Asset Management AG (Encavis AM) remains on a growth path in 2022.

Key Points: 
  • Encavis Asset Management AG (Encavis AM) remains on a growth path in 2022.
  • The Supervisory Board has appointed Alexander Sttz as a member of the Executive Board for another 3 years until December 2025.
  • Dr Christoph Husmann, Chairman of the Supervisory Board: "Alexander Sttz has played a significant role in the success story of Encavis Asset Management.
  • About Encavis Asset Management AG:
    Encavis Asset Management AG offers institutional investors tailor-made portfolios and fund solutions for investments in the growth market of Renewable Energies.

EQS-News: Evotec launches PanOmics data analysis platform PanHunter at Bio-IT World

Retrieved on: 
Saturday, October 22, 2022
LinkedIn, Multiomics, Disease, Therapy, Science, ESG, NASDAQ, Patient, Biotechnology, Bio-Rad Laboratories, Twitter, MDAX, ISIN, Knowledge, Software, Drug discovery, Frankfurt Stock Exchange, Reading, Neurology, News, EVO, Communication, Security (finance), Pharmaceutical industry, Evotec

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced the launch of the first commercial version of its PanOmics data analysis platform PanHunter at Bio-IT World (18-19 October in Berlin, Germany).

Key Points: 
  • Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced the launch of the first commercial version of its PanOmics data analysis platform PanHunter at Bio-IT World (18-19 October in Berlin, Germany).
  • PanHunter is Evotecs PanOmics data access and analytics platform and was developed and used successfully internally and in industry-shaping drug discovery partnerships over many years.
  • The amount of available PanOmics data is growing at exponential rates in the public domain and in the pharmaceutical industry.
  • PanHunter is unique in its ability to integrate the analysis of PanOmics data, designed as an easy-to-use yet fully comprehensive PanOmics data analysis platform.

TIAP and Evotec Expand LAB150 BRIDGE Partnership to Include Amgen

Retrieved on: 
Monday, October 17, 2022
Health, Other Science, Research, Pharmaceutical, Science, Biotechnology, LinkedIn, Disease, Therapy, Fortune, Efficiency, Amgen, Federal Economic Development Initiative for Northern Ontario, Science, Dow Jones Industrial Average, NASDAQ, Patient, Barron's, Investor, Biotechnology, Biology, Research, Twitter, Program, MDAX, Partnership, ISIN, University, Drug discovery, The 1972 Annual World's Best SF, Frankfurt Stock Exchange, Industry, Neurology, General Grievous, CEO, Ecosystem, Genetics, Federal Economic Development Agency for Southern Ontario, EVO, Biomedical Research, Solution, Pharmaceutical industry, Fine chemical, Evotec, Greater Toronto Area

Toronto Innovation Acceleration Partners (TIAP) and Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that the two companies have expanded LAB150, their translational BRIDGE partnership, to include Amgen as a strategic partner.

Key Points: 
  • Toronto Innovation Acceleration Partners (TIAP) and Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that the two companies have expanded LAB150, their translational BRIDGE partnership, to include Amgen as a strategic partner.
  • LAB150 was created by TIAP and Evotec in 2017 to accelerate Torontos academic research into market-ready products.
  • Amgen will provide financial support for chosen LAB150 projects along with significant mentorship from their drug discovery and development teams.
  • Together with Evotec, we look forward to collaborating with Amgen to bring enhanced expertise and capital to LAB150 to enable life science company creation, said Parimal Nathwani, President and CEO of TIAP.

EQS-News: SÜSS MicroTec SE: Dr. Goetz M. Bendele announces break until 31 December 2022 from his office as CEO of SÜSS MicroTec SE / Dr. Bernd Schulte takes over the Management Board position for this period

Retrieved on: 
Monday, October 17, 2022
MDAX, Investor relations, Development, SUSS, Federation of Public and Private Sector Employees, SÜSS MicroTec, Supervisory board, Private, Family, Financial Oversight and Management Board for Puerto Rico, Â, SE, Workforce, Woman, LED, MEMS, ISIN, Aktiengesellschaft, Public, CEO, Deutsch, Communication, Solution, Management, Property management, Man, Research

SSS MicroTec SE: Dr. Goetz M. Bendele announces break until 31 December 2022 from his office as CEO of SSS MicroTec SE / Dr. Bernd Schulte takes over the Management Board position for this period

Key Points: 
  • SSS MicroTec SE: Dr. Goetz M. Bendele announces break until 31 December 2022 from his office as CEO of SSS MicroTec SE / Dr. Bernd Schulte takes over the Management Board position for this period
    The issuer is solely responsible for the content of this announcement.
  • For the duration of absence, the Supervisory Board has appointed its member Dr. Bernd Schulte to the Management Board of SSS MicroTec SE, where he will also take over as its Chair.
  • Through his work on the Supervisory Board of SSS MicroTec SE, Dr. Bernd Schulte is very familiar with the company.
  • Following his temporary role in the Management Board, Dr. Bernd Schulte will return to the Supervisory Board of SSS MicroTec SE.

EQS-News: TeamViewer ranks among Top 3 in Sustainalytics ESG risk rating

Retrieved on: 
Thursday, October 6, 2022
Risk, Augmented reality, ESG, Research, TeamViewer, MDAX, Sustainalytics, EUR, Automation, Frankfurt Stock Exchange, Industry, Internet, Artificial intelligence, TMV, TeamViewer (company), Lithium

In September 2022, TeamViewer received an ESG Risk Rating of 9.9 and was assessed by Sustainalytics to be at negligible risk of experiencing material financial impacts from ESG factors.

Key Points: 
  • In September 2022, TeamViewer received an ESG Risk Rating of 9.9 and was assessed by Sustainalytics to be at negligible risk of experiencing material financial impacts from ESG factors.
  • Sustainalytics ESG Risk Ratings measure a companys exposure to industry-specific material ESG risks and how well a company is managing those risks.
  • This multi-dimensional way of measuring ESG risk combines the concepts of management and exposure to arrive at an assessment of ESG risk, i.e.
  • a total unmanaged ESG risk score or the ESG Risk Rating, that is comparable across all industries.

TeamViewer and Hyundai Motor Sign Strategic Partnership to Accelerate Digital Innovation in Automotive Smart Factory

Retrieved on: 
Friday, September 30, 2022
Metaverse, Group, TeamViewer (company), AAM, Workforce, TeamViewer, Safety, Mixed Reality, Efficiency, Augmented reality, AR, MDAX, Hyundai Motor Company, Frankfurt Stock Exchange, Partnership, Industry, Maintenance, TMV, Automation, Internet, Technology, Solution, Humanity, Robotics, EUR, EV, Research, R, AI, Artificial intelligence, Motor vehicle, Mobile phone, Hyundai

TeamViewer and Hyundai Motor Company will cooperate to maximize digitalization benefits in HMGICS' smart factory using TeamViewer's Augmented Reality (AR) platform, which includes Mixed Reality (MR) and Artificial Intelligence (AI) capabilities.

Key Points: 
  • TeamViewer and Hyundai Motor Company will cooperate to maximize digitalization benefits in HMGICS' smart factory using TeamViewer's Augmented Reality (AR) platform, which includes Mixed Reality (MR) and Artificial Intelligence (AI) capabilities.
  • The two companies will conduct joint research and development (R&D) activities in AR-powered smart factory operations, immersive digital experience for frontline workers and AI support for a future automotive factory.
  • We expect the partnership will further accelerate our transition to smart factory and enhance its efficiency."
  • Sojung Lee, President of TeamViewer Asia Pacific, said: "We are excited to collaborate with Hyundai Motor Company in digitalizing manufacturing processes and building an automotive factory of the future.

TeamViewer Remote Access and Support Enables Health Point Neurodiagnostics to Ensure the Reliability and Quality of EEG Devices

Retrieved on: 
Tuesday, September 27, 2022
HIPPA, TeamViewer (company), Workforce, TeamViewer, Augmented reality, MDAX, Health, Frankfurt Stock Exchange, Industry, TMV, Patient, Automation, Internet, Support, Solution, EUR, EEG, Artificial intelligence, Medical device

TAMPA BAY, Fla., Sept. 27, 2022 /PRNewswire/ -- Health Point Neurodiagnostics, a premier remote diagnostic test provider, is using TeamViewer to increase the reliability and quality of their remote EEG ambulatory mobile testing. Thanks to TeamViewer's secure Remote Access and Support solution, Health Point Neurodiagnostics technicians can conduct intermittent monitoring every two hours to ensure the EEG records and video data quality is as expected.

Key Points: 
  • TAMPA BAY, Fla., Sept. 27, 2022 /PRNewswire/ -- Health Point Neurodiagnostics, a premier remote diagnostic test provider, is using TeamViewer to increase the reliability and quality of their remote EEG ambulatory mobile testing.
  • Thanks to TeamViewer's secure Remote Access and Support solution, Health Point Neurodiagnostics technicians can conduct intermittent monitoring every two hours to ensure the EEG records and video data quality is as expected.
  • To date, Health Point Neurodiagnostics has easily passed every audit conducted while using the TeamViewer software and connection reporting system.
  • "It's vital for us to ensure the reliability and quality of our EEG devices for our patients," says Kris Raymer, Chief Technology Officer at Health Point Neurodiagnostics.

EQS-News: Just – Evotec Biologics awarded contract from the U.S. Department of Defense under accelerated antibodies program

Retrieved on: 
Tuesday, September 20, 2022
Linda, JUST, Efficiency, Joint Program Executive Office Chemical and Biological Defense, U.S. Department of Defense Strategy for Operating in Cyberspace, Patient, Frankfurt Stock Exchange, EQS, Technology, NASDAQ, EVO, Radiation, Time, ISIN, BARDA, CGMP, THE, Program, Immortalised cell line, JPL, DOD, Science, ESG, MDAX, Plague, News, Partnership, Â, Automation, Artificial intelligence, Neurology, Therapy, Communication, Development, Machine learning, Twitter, Infection, Biomedical Advanced Research and Development Authority, LinkedIn, Just, Neutralizing antibody, Biotechnology, Security (finance), Vaccine, Pharmaceutical industry, Risk management, Fine chemical, Chemical substance, Evotec, Defense

Just Evotec Biologics awarded contract from the U.S. Department of Defense under accelerated antibodies program

Key Points: 
  • Just Evotec Biologics awarded contract from the U.S. Department of Defense under accelerated antibodies program
    The issuer is solely responsible for the content of this announcement.
  • Plague, an infectious disease caused by the bacterium Yersinia pestis (Y. pestis), is one of the designated targets of interest under the DODs Accelerated Antibodies Program.
  • The advanced Just Evotec Biologics platform is specifically well suited for monoclonal antibodies as well as other protein modalities such as Fc fusion proteins.
  • Just Evotec Biologics J.POD Redmond, Washington biologics development and cGMP manufacturing facility will develop mAb-based drug products for the US Department of Defense.